Veracyte (VCYT)
Develops molecular tests that guide cancer diagnosis, treatment, and recurrence monitoring.
$32.13
After hours−11.23 (−25.90%)
At close$43.36(+4.43%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
$0.43
Revenue estimate
$147.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$0.07$0.31$0.44$0.51$0.53$0.52$0.54Pending
Estimate$0.10$0.12$0.31$0.32$0.41$0.34$0.41$0.43
Surprise−30.0%+151.8%+41.9%+59.4%+29.8%+52.9%+31.6%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$118.6M$114.5M$130.2M$131.9M$140.6M$139.1M$150.3MPending
Estimate$116.7M$111.3M$121.0M$125.0M$135.8M$130.4M$144.6M$147.2M
Surprise+1.7%+2.9%+7.6%+5.5%+3.6%+6.7%+4.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.59 | — | — |
| Sep 2028 | $0.56 | — | — |
| Jun 2028 | $0.56 | — | — |
| Mar 2028 | $0.53 | — | — |
| Dec 2027 | $0.52 | — | — |
| Sep 2027 | $0.48 | — | — |
| Jun 2027 | $0.49 | — | — |
| Mar 2027 | $0.45 | — | — |
| Dec 2026 | $0.45 | — | — |
| Nov 2026 | $0.43 | — | — |
| Jul 2026 | $0.41 | $0.54 | +31.6% |
| May 2026 | $0.34 | $0.52 | +52.9% |
| Feb 2026 | $0.41 | $0.53 | +29.8% |
| Nov 2025 | $0.32 | $0.51 | +59.4% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.59 | — | — | $189.7M | — | — | — |
| Sep 2028 | $0.56 | — | — | $179.9M | — | — | — |
| Jun 2028 | $0.56 | — | — | $179.2M | — | — | — |
| Mar 2028 | $0.53 | — | — | $167.6M | — | — | — |
| Dec 2027 | $0.52 | — | — | $176.2M | — | — | — |
| Sep 2027 | $0.48 | — | — | $165.6M | — | — | — |
| Jun 2027 | $0.49 | — | — | $163.2M | — | — | — |
| Mar 2027 | $0.45 | — | — | $153.6M | — | — | — |
| Dec 2026 | $0.45 | — | — | $157.3M | — | — | — |
| Nov 3, 2026 | $0.43 | — | — | $147.2M | — | — | — |
| Jul 30, 2026 | $0.41 | $0.54 | +31.6% | $144.6M | $150.3M | +4.0% | −22.5% |
| May 5, 2026 | $0.34 | $0.52 | +52.9% | $130.4M | $139.1M | +6.7% | +24.9% |
| Feb 25, 2026 | $0.41 | $0.53 | +29.8% | $135.8M | $140.6M | +3.6% | +8.5% |
| Nov 4, 2025 | $0.32 | $0.51 | +59.4% | $125.0M | $131.9M | +5.5% | +27.5% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 24, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 22, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Jul 29, 2021 | |||||||
| May 10, 2021 | |||||||
| Feb 17, 2021 | |||||||
| Nov 2, 2020 | |||||||
| Jul 30, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Oct 22, 2019 | |||||||
| Jul 30, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Feb 25, 2019 | |||||||
| Oct 29, 2018 | |||||||
| Jul 23, 2018 | |||||||
| May 1, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Jul 31, 2017 | |||||||
| May 3, 2017 | |||||||
| Mar 1, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 5, 2016 | |||||||
| Mar 10, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 13, 2015 |